Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| smooth muscle cell | 12 studies | 25% ± 6% | |
| pericyte | 11 studies | 26% ± 7% | |
| type II pneumocyte | 10 studies | 37% ± 11% | |
| glutamatergic neuron | 7 studies | 34% ± 16% | |
| goblet cell | 6 studies | 33% ± 18% | |
| GABAergic neuron | 5 studies | 40% ± 13% | |
| interneuron | 4 studies | 50% ± 24% | |
| plasma cell | 4 studies | 23% ± 4% | |
| retinal pigment epithelial cell | 4 studies | 39% ± 13% | |
| pancreatic A cell | 3 studies | 47% ± 26% | |
| type B pancreatic cell | 3 studies | 51% ± 20% | |
| mesothelial cell | 3 studies | 23% ± 5% | |
| endothelial cell | 3 studies | 25% ± 6% | |
| cardiac muscle cell | 3 studies | 18% ± 2% | |
| muscle cell | 3 studies | 37% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 11149.71 | 245 / 245 | 98% | 110.82 | 490 / 502 |
| thymus | 100% | 24119.57 | 653 / 653 | 96% | 175.56 | 579 / 605 |
| intestine | 99% | 7292.80 | 953 / 966 | 87% | 93.66 | 461 / 527 |
| pancreas | 99% | 4112.32 | 326 / 328 | 85% | 58.11 | 151 / 178 |
| lung | 96% | 5555.96 | 552 / 578 | 75% | 80.14 | 871 / 1155 |
| kidney | 100% | 5773.21 | 89 / 89 | 64% | 35.15 | 580 / 901 |
| adrenal gland | 89% | 5285.49 | 230 / 258 | 72% | 262.64 | 166 / 230 |
| bladder | 100% | 11033.38 | 21 / 21 | 56% | 43.68 | 282 / 504 |
| breast | 99% | 7160.84 | 454 / 459 | 52% | 22.56 | 580 / 1118 |
| uterus | 99% | 7298.86 | 168 / 170 | 37% | 25.10 | 168 / 459 |
| stomach | 52% | 1233.71 | 185 / 359 | 70% | 61.77 | 201 / 286 |
| adipose | 100% | 9250.09 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 14678.94 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| esophagus | 62% | 1722.07 | 893 / 1445 | 37% | 24.71 | 67 / 183 |
| ovary | 89% | 4483.72 | 160 / 180 | 4% | 1.75 | 18 / 430 |
| heart | 93% | 8156.78 | 798 / 861 | 0% | 0 | 0 / 0 |
| brain | 50% | 2315.30 | 1326 / 2642 | 36% | 14.62 | 255 / 705 |
| spleen | 79% | 2047.25 | 191 / 241 | 0% | 0 | 0 / 0 |
| skin | 49% | 1634.46 | 886 / 1809 | 13% | 4.73 | 60 / 472 |
| muscle | 53% | 1335.89 | 423 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 52% | 25.46 | 15 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 51% | 67.09 | 23 / 45 |
| liver | 0% | 7.02 | 1 / 226 | 7% | 2.32 | 28 / 406 |
| peripheral blood | 7% | 247.19 | 64 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 3% | 0.73 | 2 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0051973 | Biological process | positive regulation of telomerase activity |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0010008 | Cellular component | endosome membrane |
| GO_0000139 | Cellular component | Golgi membrane |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005770 | Cellular component | late endosome |
| GO_0005769 | Cellular component | early endosome |
| GO_0005515 | Molecular function | protein binding |
| Gene name | PARM1 |
| Protein name | Prostate androgen-regulated mucin-like protein 1 Prostate androgen-regulated mucin-like protein 1 (PARM-1) |
| Synonyms | UNQ1879/PRO4322 |
| Description | FUNCTION: May regulate TLP1 expression and telomerase activity, thus enabling certain prostatic cells to resist apoptosis. . |
| Accessions | ENST00000513238.5 ENST00000307428.7 Q6UWI2 D6RBB6 |